Sensodetect AB logo

Sensodetect AB (SDET)

Market Closed
12 Jun, 15:25
XSTO XSTO
kr
0. 00
-0
-27.2727%
kr
37.23M Market Cap
- P/E Ratio
- Div Yield
58.1M Volume
- Eps
kr 0
Previous Close
Add Transaction
Day Range
0 0.01
Year Range
0 0
Want to track SDET and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SDET closed Friday lower at kr0, a decrease of -27.2727% from Thursday's close, completing a monthly increase of 0% or kr0. Over the past 12 months, SDET stock gained 0%.
SDET is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

SDET Chart

People also search for

OncoZenge AB
kr 5.75
-7.4074%
FRISQ Holding AB
kr 0.7
+6.383%
ScandiDos AB
kr 0.92
+2.809%
GPX Medical AB
kr 2.13
-0.9302%
Redsense Medical AB
kr 4
+0.2506%

Sensodetect AB (SDET) FAQ

What is the stock price today?

The current price is kr0.00.

On which exchange is it traded?

Sensodetect AB is listed on XSTO.

What is its stock symbol?

The ticker symbol is SDET.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 37.23M.

Has Sensodetect AB ever had a stock split?

No, there has never been a stock split.

Sensodetect AB Profile

Health Care Technology Industry
Healthcare Sector
Mr. Per-Anders Hedin CEO
XSTO Exchange
- ISIN
SE Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

SensoDetect Aktiebolag (publ) represents a significant advancement in the field of medical technology, particularly within the artificial intelligence sector focused on mental health. Established in 2005 and headquartered in Malmö, Sweden, this company pioneers in the development of groundbreaking solutions aimed at improving the lives of individuals suffering from mental illnesses. By leveraging artificial intelligence, SensoDetect Aktiebolag (publ) has positioned itself as a crucial entity in the psychiatric care arena, providing innovative diagnostic aids and treatment monitoring tools to healthcare professionals.

Products and Services

  • SensoDetect BERA
  • This diagnostic aid is a cornerstone of SensoDetect Aktiebolag (publ)'s product offerings. Specifically designed for healthcare professionals within psychiatric care, it serves as an invaluable tool for the diagnosis of ADHD and autism. Beyond its diagnostic capabilities, SensoDetect BERA also assists in the monitoring of treatment efficacy for various psychiatric conditions, offering a comprehensive approach to mental health care.

Contact Information

Address: The Point, Malmö, Sweden, 215 32
Phone: 46 46 15 79 04